Adherence to artemether/lumefantrine treatment in children under real-life situations in rural Tanzania

Daudi O Simba1, Deodatus Kakoko, Goran Tomson

  • 1Department of Community Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. dsimba@muhas.ac.tz

Insights

High adherence to artemether/lumefantrine (ALu) malaria treatment was reported in rural Tanzania. Factors like household wealth influenced adherence, crucial for preventing drug resistance.

Area of Science:

  • Malariology
  • Pharmacology
  • Global Health

Background:

  • Artemether/lumefantrine (ALu) is a key malaria treatment.
  • Understanding adherence is vital for treatment efficacy and resistance prevention.

Purpose of the Study:

  • To assess adherence to ALu treatment in rural Tanzania.
  • To identify factors associated with ALu adherence.
  • To measure lumefantrine concentrations in children.

Main Methods:

  • Follow-up study in five Tanzanian villages.
  • Home visits on Day 7 post-treatment for adherence interviews.
  • Malaria rapid diagnostic tests and capillary blood collection for lumefantrine levels.

Main Results:

  • 88.3% of children reportedly received all ALu doses on time.
  • Non-adherence was primarily due to untimeliness, especially for later doses.
  • No significant difference in blood lumefantrine concentrations between adherent and non-adherent groups.
  • Children from less poor households showed higher adherence (aOR=2.23).

Conclusions:

  • Reported ALu adherence in rural Tanzania is high and encouraging.
  • Socioeconomic status is a factor influencing adherence.
  • Variability in lumefantrine levels may stem from dosage and healthcare worker practices.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.